Literature DB >> 28413986

Tau in Alzheimer's Disease: Mechanisms and Therapeutic Strategies.

Yu Gao1, Lin Tan1,2, Jin-Tai Yu1, Lan Tan1.   

Abstract

OBJECTIVE: Alzheimer's disease (AD), the most important progressive neurodegenerative disorder, is characterized by cognitive and behavioral disabilities. Nowadays, tau, as a microtubuleassociated protein and a principle neuropathological hallmark of AD, provides us a neoteric perspective to explore further aetiopathogenesis and therapeutic strategy. The hyperphosphorylation and abnormal aggregation of tau, combined with its decreased clearance, form neurofibrillary tangles (NFTs) and exert neurotoxicity in AD.
METHODS: Recent investigations aim to prevent the deposition of NFT and accelerate the clearance of NFT. Intriguingly, immunization strategies targeting tau effectively ameliorates the tau-associated pathology in AD. In addition, modified therapies targeting tau should be regarded as a potential way to treat AD. These progresses open new avenues for AD.
CONCLUSION: Here, we review the recent literature of potential mechanisms of the tau in AD and discuss the modified therapeutic strategies for AD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; NFTs; Tau; aggregation; phosphorylation; therapy.

Mesh:

Substances:

Year:  2018        PMID: 28413986     DOI: 10.2174/1567205014666170417111859

Source DB:  PubMed          Journal:  Curr Alzheimer Res        ISSN: 1567-2050            Impact factor:   3.498


  59 in total

Review 1.  ReMAPping the microtubule landscape: How phosphorylation dictates the activities of microtubule-associated proteins.

Authors:  Amrita Ramkumar; Brigette Y Jong; Kassandra M Ori-McKenney
Journal:  Dev Dyn       Date:  2017-10-27       Impact factor: 3.780

2.  Additional methodological considerations regarding optimization of the dose of intracerebroventricular streptozotocin A response to: "Optimization of intracerebroventricular streptozotocin dose for the induction of neuroinflammation and memory impairments in rats" by Ghosh et al., Metab Brain Dis 2020 July 21.

Authors:  Jan Homolak; Ana Babic Perhoc; Ana Knezovic; Jelena Osmanovic Barilar; Melita Salkovic-Petrisic
Journal:  Metab Brain Dis       Date:  2020-10-27       Impact factor: 3.584

3.  Levistolide A Attenuates Alzheimer's Pathology Through Activation of the PPARγ Pathway.

Authors:  Xiaodan Qu; Peipei Guan; Li Han; Zhanyou Wang; Xueshi Huang
Journal:  Neurotherapeutics       Date:  2020-10-09       Impact factor: 7.620

4.  Genipin Attenuates Tau Phosphorylation and Aβ Levels in Cellular Models of Alzheimer's Disease.

Authors:  Meiting Li; Nan Cai; Liang Gu; Lijun Yao; Decheng Bi; Weishan Fang; Zhijian Lin; Yan Wu; Hong Xu; Hui Li; Zhangli Hu; Xu Xu
Journal:  Mol Neurobiol       Date:  2021-05-04       Impact factor: 5.590

5.  Treadmill Exercise Alleviates Brain Iron Dyshomeostasis Accelerating Neuronal Amyloid-β Production, Neuronal Cell Death, and Cognitive Impairment in Transgenic Mice Model of Alzheimer's Disease.

Authors:  Dong-Hun Choi; Ki-Chun Kwon; Dong-Joo Hwang; Jung-Hoon Koo; Hyun-Seob Um; Hong-Sun Song; Ji-Sun Kim; Yongchul Jang; Joon-Yong Cho
Journal:  Mol Neurobiol       Date:  2021-02-28       Impact factor: 5.590

6.  SIRT1-Dependent Upregulation of BDNF in Human Microglia Challenged with Aβ: An Early but Transient Response Rescued by Melatonin.

Authors:  Grazia Ilaria Caruso; Simona Federica Spampinato; Giuseppe Costantino; Sara Merlo; Maria Angela Sortino
Journal:  Biomedicines       Date:  2021-04-24

7.  Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders.

Authors:  Brian Spencer; Sven Brüschweiler; Marco Sealey-Cardona; Edward Rockenstein; Anthony Adame; Jazmin Florio; Michael Mante; Ivy Trinh; Robert A Rissman; Robert Konrat; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2018-06-14       Impact factor: 17.088

Review 8.  Autophagic Pathways to Clear the Tau Aggregates in Alzheimer's Disease.

Authors:  Nalini Vijay Gorantla; Subashchandrabose Chinnathambi
Journal:  Cell Mol Neurobiol       Date:  2020-06-11       Impact factor: 5.046

Review 9.  Therapeutic Opportunities of Interleukin-33 in the Central Nervous System.

Authors:  Yun Sun; Yankai Wen; Luxi Wang; Liang Wen; Wendong You; Shuang Wei; Lin Mao; Hao Wang; Zuobing Chen; Xiaofeng Yang
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 10.  Calcium Dyshomeostasis in Alzheimer's Disease Pathogenesis.

Authors:  Roberta Cascella; Cristina Cecchi
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.